BBS1 (BBSome complex member BBS1) variants and mutations
BBS1 (also known as BBSome complex member BBS1) is a human protein-coding gene encoding a BBSome complex member protein. Within the BBSome, it helps control trafficking of membrane proteins into and out of primary cilia. Biallelic pathogenic variants cause Bardet-Biedl syndrome, with retinal degeneration, obesity, renal abnormalities, polydactyly, and variable neurodevelopmental features. This analysis covers 912 BBS1 variants and mutations. Of these, 85% have computational variant effect predictions. Disease context includes Bardet-Biedl syndrome 1, Bardet-Biedl syndrome, and retinitis pigmentosa. Example BBS1 variants include M1I, M1L, and M1T.
Variant analysis overview
- Gene: BBS1
- Protein: BBSome complex member BBS1
- UniProt accession: Q8NFJ9
- Organism: Homo sapiens
- Variants analyzed: 912
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 713 unspecified-consequence records; 103 missense variants; 60 synonymous variants; 18 frameshift variants; 5 stop-gained variants; 5 splice-region variants; 1 in-frame insertions; 1 stop lost; 1 in-frame deletions; 3 substitution
- Prediction scores: 773 variants have prediction scores (85% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Bardet-Biedl syndrome 1, Bardet-Biedl syndrome, retinitis pigmentosa, Retinal dystrophy, hereditary disease, Bardet-Biedl syndrome 13, Bardet-Biedl syndrome 11, polydactyly, BBS1-related ciliopathy, severe early-childhood-onset retinal dystrophy, retinal disorder, Usher syndrome.
Protein structure and variant hotspots
- Protein features: 1 post-translational modification sites.
- PTM context: 5 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable BBS1 variants
Examples include M1I, M1L, M1T, M1V, A2G, A2T, A2V, A2D. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1855918305, ClinGen CA381453166, ClinVar RCV002923444, ClinVar RCV005050662, MetaLR 0.92, MetaSVM 1.00, Pathogenic, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- M1L (p.Met1Leu), rs1306821707, ClinGen CA381453162, ClinVar RCV000669884, ClinVar RCV001855530, MetaLR 0.87, MetaSVM 0.70, Likely pathogenic, Bardet-Biedl syndrome 1
- M1T (p.Met1Thr), rs1222159281, ClinGen CA381453164, ClinVar RCV002770915, ClinVar RCV005635618, MetaLR 0.92, MetaSVM 1.02, Pathogenic/Likely pathogenic, Bardet-Biedl syndrome 1; Bardet-Biedl syndrome
- M1V (p.Met1Val), rs1306821707, ClinGen CA381453161, ClinVar RCV001953605, ClinVar RCV005050484, MetaLR 0.87, MetaSVM 0.70, Pathogenic/Likely pathogenic, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- A2G (p.Ala2Gly), TOPMed rs1232711188, REVEL 0.47, CADD 24.00
- A2T (p.Ala2Thr), ESP rs148912186, TOPMed rs148912186, REVEL 0.49, CADD 25.20
- A2V (p.Ala2Val), TOPMed rs1232711188
- A2D (p.Ala2Asp), gnomAD 11-66510664-C-A, REVEL 0.54, CADD 24.50
- A2A (p.Ala2Ala), rs143592479, gnomAD 11-66510665-C-T, CADD 1.06
- A3S (p.Ala3Ser), rs562874449, ClinGen CA381453177, ClinVar RCV002970700, ClinVar RCV004744500, REVEL 0.30, CADD 20.70, Uncertain significance, Bardet-Biedl syndrome
- A3T (p.Ala3Thr), 1000Genomes rs562874449, ExAC rs562874449, gnomAD rs562874449, REVEL 0.25, CADD 21.40, Uncertain significance
- A3V (p.Ala3Val), Ensembl rs1444373737, REVEL 0.40, CADD 19.80
- A3G (p.Ala3Gly), gnomAD 11-66510667-C-G, REVEL 0.32, CADD 21.60
- A3A (p.Ala3Ala), rs1197381505, gnomAD 11-66510668-T-G, CADD 4.61
- A4P (p.Ala4Pro), ExAC rs745375133, TOPMed rs745375133, gnomAD rs745375133, REVEL 0.25, CADD 13.90, Uncertain significance
- A4S (p.Ala4Ser), rs745375133, ClinGen CA6123178, ClinVar RCV001883574, ClinVar RCV002482621, REVEL 0.21, CADD 5.67, Uncertain significance, BBS1-related disorder; Inborn genetic diseases; Bardet-Biedl syndrome 1
- A4V (p.Ala4Val), TOPMed rs1855918672, REVEL 0.26, CADD 13.80
- A4A (p.Ala4Ala), rs754161831, gnomAD 11-66510671-G-C, CADD 8.54
- S5A (p.Ser5Ala), gnomAD rs1188623243
- S5F (p.Ser5Phe), rs755308059, ClinGen CA6123181, ClinVar RCV003087928, ClinVar RCV003420331, REVEL 0.34, CADD 16.90, Uncertain significance, Bardet-Biedl syndrome
- S5C (p.Ser5Cys), gnomAD 11-66510673-C-G, REVEL 0.38, CADD 17.30
- S5S (p.Ser5Ser), gnomAD 11-66510674-C-G, CADD 6.54
- S6L (p.Ser6Leu), ExAC rs748399641, TOPMed rs748399641, gnomAD rs748399641, REVEL 0.19, CADD 21.60
- S6* (p.Ser6Ter), gnomAD 11-66510676-C-A, CADD 34.00
- S6S (p.Ser6Ser), rs758441011, gnomAD 11-66510677-A-T, CADD 3.79
- S7P (p.Ser7Pro), TOPMed rs903736005, gnomAD rs903736005, Uncertain significance
- S7T (p.Ser7Thr), TOPMed rs903736005, gnomAD rs903736005, REVEL 0.28, CADD 9.28, Uncertain significance, Bardet-Biedl syndrome 1; Inborn genetic diseases
- S7I (p.Ser7Ile), rs1166022838, gnomAD 11-66510675-T-TC, CADD 19.40
- S7L (p.Ser7Leu), gnomAD 11-66510679-C-T, REVEL 0.33, CADD 17.90
- S7S (p.Ser7Ser), rs745789744, gnomAD 11-66510680-G-A, CADD 11.80
- D8N (p.Asp8Asn), NCI-TCGA Cosmic COSV5915, cosmic curated COSV59151, Variant assessed as somatic; moderate impact.
- D8V (p.Asp8Val), gnomAD 11-66510682-A-T, REVEL 0.52, CADD 27.40
- D8G (p.Asp8Gly), gnomAD 11-66510682-A-G, REVEL 0.37, CADD 25.30
- D8D (p.Asp8Asp), rs55848325, gnomAD 11-66510683-T-C, CADD 13.70
- S9C (p.Ser9Cys), TOPMed rs1432515630, gnomAD rs1432515630, REVEL 0.28, CADD 8.30
- S9F (p.Ser9Phe), gnomAD 11-66510685-C-T, REVEL 0.33, CADD 7.39
- S9S (p.Ser9Ser), rs373772468, gnomAD 11-66510686-C-T, CADD 8.12
- D10E (p.Asp10Glu), TOPMed rs1360969412, gnomAD rs1360969412, REVEL 0.26, CADD 7.88
- D10V (p.Asp10Val), gnomAD 11-66510688-A-T, REVEL 0.35, CADD 20.30
- D10D (p.Asp10Asp), gnomAD 11-66510689-C-T, CADD 7.58
- A11S (p.Ala11Ser), cosmic curated COSV10056, gnomAD rs1228682382, REVEL 0.39, CADD 0.01
- A11V (p.Ala11Val), rs150122944, ClinGen CA6123188, ClinVar RCV001876681, 1000Genomes rs150122944, REVEL 0.19, CADD 15.80, Uncertain significance, Bardet-Biedl syndrome
- A11T (p.Ala11Thr), gnomAD 11-66510690-G-A, REVEL 0.26, CADD 0.08
- A11A (p.Ala11Ala), rs1336755113, gnomAD 11-66510692-C-A, CADD 12.90
- C12R (p.Cys12Arg), Ensembl rs2134764307
- C12Y (p.Cys12Tyr), rs377507675, ClinGen CA224071095, ClinVar RCV003074004, ESP rs377507675, REVEL 0.26, CADD 15.20, Uncertain significance, Bardet-Biedl syndrome
- C12G (p.Cys12Gly), gnomAD 11-66510693-T-G, REVEL 0.39, CADD 9.28
- C12W (p.Cys12Trp), gnomAD 11-66510695-C-G, REVEL 0.34, CADD 22.60
- C12* (p.Cys12Ter), gnomAD 11-66510695-C-A, CADD 35.00
- G13E (p.Gly13Glu), 1000Genomes rs571597274, ExAC rs571597274, gnomAD rs571597274, REVEL 0.28, CADD 7.47
- A14D (p.Ala14Asp), ExAC rs774110999, TOPMed rs774110999, gnomAD rs774110999, REVEL 0.27, AlphaMissense 0.08, Pathogenic
- A14G (p.Ala14Gly), rs774110999, ClinGen CA381453346, ClinVar RCV000585181, ClinVar RCV001199647, REVEL 0.25, AlphaMissense 0.08, Conflicting interpretations, not provided; Retinitis pigmentosa
- A14S (p.Ala14Ser), Ensembl rs1855919917
- A14V (p.Ala14Val), rs774110999, ClinGen CA381453348, ClinVar RCV003859222, ExAC rs774110999, AlphaMissense 0.08, MetaLR 0.74, Uncertain significance, Bardet-Biedl syndrome
- E15D (p.Glu15Asp), cosmic curated COSV59148, ExAC rs767116799, gnomAD rs767116799, REVEL 0.39, CADD 17.30, Likely benign
- E15K (p.Glu15Lys), rs761601575, ClinGen CA6123191, NCI-TCGA Cosmic COSV5914, cosmic curated COSV59149, REVEL 0.47, CADD 23.90, Uncertain significance, Bardet-Biedl syndrome 1; Bardet-Biedl syndrome
- S16C (p.Ser16Cys), rs772917364, ClinGen CA6123193, ClinVar RCV000782273, ClinVar RCV004817985, REVEL 0.61, CADD 34.00, Likely pathogenic, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1; Retinal dystrophy
- S16G (p.Ser16Gly), ExAC rs772917364, gnomAD rs772917364, Likely pathogenic
- S16N (p.Ser16Asn), cosmic curated COSV10738, Ensembl rs1855920301, REVEL 0.33, CADD 33.00
- S16Q (p.Ser16Gln), rs1291184039, gnomAD 11-66510701-TGA-T, CADD 25.60
- S16S (p.Ser16Ser), rs200255383, gnomAD 11-66511013-C-T, CADD 19.30
- N17H (p.Asn17His), TOPMed rs1855931484
- N17S (p.Asn17Ser), gnomAD rs1231862256, REVEL 0.24, CADD 8.08
- N17K (p.Asn17Lys), gnomAD 11-66511016-T-G, REVEL 0.27, CADD 4.60
- E18K (p.Glu18Lys), NCI-TCGA Cosmic COSV5914, cosmic curated COSV59148, Ensembl rs1855931587, REVEL 0.49, CADD 28.60, Variant assessed as somatic; moderate impact.
- E18G (p.Glu18Gly), gnomAD 11-66511018-A-G, REVEL 0.73, CADD 25.30
- E18E (p.Glu18Glu), rs761128852, gnomAD 11-66511019-G-A, CADD 9.19
- A19T (p.Ala19Thr), cosmic curated COSV10056, ExAC rs753795220, TOPMed rs753795220, gnomAD rs753795220, REVEL 0.22, CADD 18.40
- A19V (p.Ala19Val), gnomAD rs1426785779, REVEL 0.27, CADD 22.30
- A19A (p.Ala19Ala), gnomAD 11-66511022-C-T, CADD 14.70
- N20S (p.Asn20Ser), rs879216710, ClinGen CA224071420, ClinVar RCV002756858, ClinVar RCV006327514, REVEL 0.29, CADD 13.50, Conflicting interpretations, Inborn genetic diseases; Bardet-Biedl syndrome
- K22R (p.Lys22Arg), gnomAD 11-66511030-A-G, REVEL 0.76, CADD 25.30
- W23* (p.Trp23Ter), rs2495728074, ClinVar RCV004573992, CADD 38.00, Likely pathogenic
- W23C (p.Trp23Cys), gnomAD 11-66511034-G-T, REVEL 0.95, CADD 32.00
- L24* (p.Leu24Ter), rs1855932058, ClinGen CA381453606, ClinVar RCV001263833, Ensembl rs1855932058, Likely pathogenic
- L24F (p.Leu24Phe), rs1855932012, gnomAD 11-66511034-G-GT, CADD 29.30
- L24L (p.Leu24Leu), rs747891096, gnomAD 11-66511035-T-C, CADD 12.60
- D25E (p.Asp25Glu), rs772010847, ClinGen CA6123230, ClinVar RCV003889600, ExAC rs772010847, REVEL 0.50, CADD 0.53, Uncertain significance, Retinal dystrophy
- D25G (p.Asp25Gly), gnomAD 11-66511039-A-G, REVEL 0.85, CADD 31.00
- A26V (p.Ala26Val), rs866558676, ClinGen CA224071421, NCI-TCGA Cosmic COSV5915, cosmic curated COSV59150, REVEL 0.82, CADD 24.90, Uncertain significance, Bardet-Biedl syndrome; Inborn genetic diseases; Bardet-Biedl syndrome 1
- A26G (p.Ala26Gly), gnomAD 11-66511042-C-G, REVEL 0.81, CADD 23.80
- A26A (p.Ala26Ala), rs2134765264, gnomAD 11-66511043-G-C, CADD 2.37
- H27L (p.His27Leu), Ensembl rs1855932207
- H27H (p.His27His), rs1461414063, gnomAD 11-66511046-C-T, CADD 11.10
- Y28C (p.Tyr28Cys), rs1263024783, ClinGen CA381453674, ClinVar RCV001987079, ClinVar RCV005050507, REVEL 0.77, CADD 26.90, Uncertain significance, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- Y28Y (p.Tyr28Tyr), rs771560964, gnomAD 11-66511049-C-T, CADD 12.10
- D29Y (p.Asp29Tyr), gnomAD 11-66511050-G-T, REVEL 0.95, CADD 32.00
- D29D (p.Asp29Asp), gnomAD 11-66511052-C-T, CADD 13.60
- P30Q (p.Pro30Gln), Ensembl rs78913093
- P30T (p.Pro30Thr), rs368510687, ClinGen CA6123232, ClinVar RCV001894400, ClinVar RCV002478136, REVEL 0.78, CADD 23.50, Uncertain significance, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- M31I (p.Met31Ile), rs1319049359, ClinGen CA381453725, ClinVar RCV002637691, TOPMed rs1319049359, AlphaMissense 0.28, MetaLR 0.48, Uncertain significance, Bardet-Biedl syndrome
- M31V (p.Met31Val), TOPMed rs201026878
- A32T (p.Ala32Thr), gnomAD rs1285370450, REVEL 0.90, CADD 26.50
- A32S (p.Ala32Ser), gnomAD 11-66511059-G-T, REVEL 0.79, CADD 25.90
- A32G (p.Ala32Gly), gnomAD 11-66511060-C-G, REVEL 0.83, CADD 28.00
- A32V (p.Ala32Val), gnomAD 11-66511060-C-T, REVEL 0.89, CADD 28.30
- A32A (p.Ala32Ala), rs776061360, gnomAD 11-66511061-C-T, CADD 14.90
- N33K (p.Asn33Lys), gnomAD 11-66511061-C-CA, CADD 28.20
- N33D (p.Asn33Asp), gnomAD 11-66511062-A-G, REVEL 0.34, CADD 23.20
- N33S (p.Asn33Ser), gnomAD 11-66511063-A-G, REVEL 0.39, CADD 21.80
- I34T (p.Ile34Thr), Ensembl rs778261474, REVEL 0.86, CADD 29.20
- I34I (p.Ile34Ile), rs760081811, gnomAD 11-66511067-C-A, CADD 15.00
- H35R (p.His35Arg), rs775990952, ClinGen CA6123237, ClinVar RCV001941125, UniProt VAR 038880, REVEL 0.79, CADD 22.90, Uncertain significance, Bardet-Biedl syndrome
- H35Y (p.His35Tyr), TOPMed rs1371485927, gnomAD rs1371485927, REVEL 0.26, CADD 19.00
- T36I (p.Thr36Ile), TOPMed rs1339000905
- T36S (p.Thr36Ser), TOPMed rs1339000905
- T36L (p.Thr36Leu), rs1223395982, gnomAD 11-66511067-CCA-C, CADD 28.60
- F37F (p.Phe37Phe), rs370608923, gnomAD 11-66511076-T-C, CADD 13.70
- S38L (p.Ser38Leu), gnomAD 11-66511073-CT-C, CADD 32.00
- S38S (p.Ser38Ser), rs1272963515, gnomAD 11-66511079-T-C, CADD 11.40
- C40A (p.Cys40Ala), rs1490351829, gnomAD 11-66511082-CT-C, CADD 32.00
- C40C (p.Cys40Cys), rs1224146191, gnomAD 11-66511085-C-T, CADD 14.30
- C40W (p.Cys40Trp), gnomAD 11-66511085-C-G, REVEL 0.80, CADD 25.20
- L41R (p.Leu41Arg), gnomAD 11-66511087-T-G, REVEL 0.88, CADD 33.00
- L41L (p.Leu41Leu), rs912081756, gnomAD 11-66511088-A-G, CADD 18.80
- p.Ala42dup, gnomAD 11-66511088-A-AGC, CADD 21.20
- A42S (p.Ala42Ser), gnomAD 11-66511089-G-T, REVEL 0.23, CADD 26.40
- A42V (p.Ala42Val), gnomAD 11-66511205-C-T, REVEL 0.39, CADD 22.60
- L43V (p.Leu43Val), rs1855936862, ClinGen CA381453983, ClinVar RCV001822800, ClinVar RCV004728834, REVEL 0.71, CADD 26.60, Uncertain significance, not specified
- L43G (p.Leu43Gly), gnomAD 11-66511089-G-GCT, CADD 30.00
- A44T (p.Ala44Thr), TOPMed rs1315550100, REVEL 0.64, CADD 29.40, Uncertain significance, Inborn genetic diseases
- A44G (p.Ala44Gly), gnomAD 11-66511211-C-G, REVEL 0.60, CADD 27.60
- A44A (p.Ala44Ala), rs2134765700, gnomAD 11-66511212-A-G, CADD 10.60
- D45E (p.Asp45Glu), gnomAD rs1380881883, REVEL 0.89, CADD 25.60
- D45Y (p.Asp45Tyr), ESP rs367682811, TOPMed rs367682811
- D45H (p.Asp45His), gnomAD 11-66511213-G-C, REVEL 0.95, CADD 33.00
- D45D (p.Asp45Asp), gnomAD 11-66511215-T-C, CADD 14.40
- L46L (p.Leu46Leu), rs1590754166, gnomAD 11-66511218-A-G, CADD 13.30
- H47R (p.His47Arg), Ensembl rs922934188
- H47M (p.His47Met), gnomAD 11-66511218-AC-A, CADD 33.00
- H47Y (p.His47Tyr), gnomAD 11-66511219-C-T, REVEL 0.53, CADD 22.70
- H47H (p.His47His), gnomAD 11-66511221-T-C, CADD 7.14
- G48R (p.Gly48Arg), ExAC rs773503074, gnomAD rs773503074, REVEL 0.89, CADD 32.00
- G48C (p.Gly48Cys), gnomAD 11-66514408-G-T, CADD 17.00
- D49H (p.Asp49His), TOPMed rs1384153100, gnomAD rs1384153100, REVEL 0.92, CADD 32.00, Uncertain significance, Bardet-Biedl syndrome 1
- D49N (p.Asp49Asn), TOPMed rs1384153100, gnomAD rs1384153100, REVEL 0.75, CADD 32.00, Uncertain significance
- D49G (p.Asp49Gly), gnomAD 11-66511221-T-TG, CADD 34.00
- G50G (p.Gly50Gly), gnomAD 11-66511230-G-C, CADD 12.80
- E51A (p.Glu51Ala), rs760793954, ClinGen CA381454134, ClinVar RCV002603652, ClinVar RCV004744606, AlphaMissense 0.62, MetaLR 0.82, Uncertain significance, Bardet-Biedl syndrome 1; Bardet-Biedl syndrome
- E51G (p.Glu51Gly), ExAC rs760793954, gnomAD rs760793954, REVEL 0.83, AlphaMissense 0.62
- E51V (p.Glu51Val), ExAC rs760793954, gnomAD rs760793954, REVEL 0.80, AlphaMissense 0.62
- E51K (p.Glu51Lys), rs11553180, gnomAD 11-66514450-G-A, CADD 13.50
- Y52H (p.Tyr52His), Ensembl rs1565280390, REVEL 0.26, CADD 22.20
- K53E (p.Lys53Glu), rs766602837, ClinGen CA6123263, ClinVar RCV000540107, ClinVar RCV001829577, REVEL 0.88, CADD 33.00, Uncertain significance, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- K53T (p.Lys53Thr), ExAC rs752658686, gnomAD rs752658686, REVEL 0.84, CADD 33.00
- K53K (p.Lys53Lys), rs1262106058, gnomAD 11-66511239-G-A, CADD 28.50
- L54A (p.Leu54Ala), rs1313590454, gnomAD 11-66511236-C-CA, CADD 32.00
- L54V (p.Leu54Val), gnomAD 11-66514406-C-G, REVEL 0.84, CADD 26.50
- V55M (p.Val55Met), rs181765153, ClinGen CA6123281, ClinVar RCV001277998, ClinVar RCV001367515, REVEL 0.78, CADD 26.20, Uncertain significance, Bardet-Biedl syndrome 1; Retinal dystrophy; Bardet-Biedl syndrome
- V55L (p.Val55Leu), gnomAD 11-66514409-G-T, REVEL 0.28, CADD 22.50
- V55A (p.Val55Ala), gnomAD 11-66514410-T-C, REVEL 0.57, CADD 22.70
- V56A (p.Val56Ala), TOPMed rs1856006907
- V56I (p.Val56Ile), ExAC rs766553514, gnomAD rs766553514, REVEL 0.38, CADD 19.80, Uncertain significance, BBS1-related disorder
- G57R (p.Gly57Arg), rs1355873337, ClinGen CA381455572, ClinVar RCV000723248, ClinVar RCV001317094, REVEL 0.88, CADD 29.00, Uncertain significance, Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- G57A (p.Gly57Ala), gnomAD 11-66514416-G-C, REVEL 0.47, CADD 19.50
- D58A (p.Asp58Ala), Ensembl rs1590756387
- D58H (p.Asp58His), rs776917681, ClinGen CA6123283, ClinVar RCV003941641, ClinVar RCV005051418, REVEL 0.96, CADD 28.90, Uncertain significance, Bardet-Biedl syndrome 1
- D58N (p.Asp58Asn), gnomAD 11-66514418-G-A, REVEL 0.81, CADD 29.70
- D58Y (p.Asp58Tyr), gnomAD 11-66514418-G-T, REVEL 0.95, CADD 32.00
- L59V (p.Leu59Val), rs113822005, ClinGen CA6123284, ClinVar RCV001212839, ClinVar RCV001819901, REVEL 0.52, CADD 23.70, Uncertain significance, not specified; Bardet-Biedl syndrome 1; Bardet-Biedl syndrome
- G60A (p.Gly60Ala), rs1361837075, ClinGen CA381455637, ClinVar RCV003033493, TOPMed rs1361837075, AlphaMissense 0.22, MetaLR 0.80, Uncertain significance, Bardet-Biedl syndrome
- G60D (p.Gly60Asp), TOPMed rs1361837075, Uncertain significance, Inborn genetic diseases
- G60V (p.Gly60Val), gnomAD 11-66514425-G-T, REVEL 0.87, CADD 28.80
- P61L (p.Pro61Leu), TOPMed rs1856007267, REVEL 0.22, CADD 18.60
- P61S (p.Pro61Ser), TOPMed rs999363451, gnomAD rs999363451, REVEL 0.27, CADD 16.40
- G62R (p.Gly62Arg), rs763878620, ClinGen CA6123286, ClinVar RCV001938327, ExAC rs763878620, REVEL 0.23, CADD 21.30, Uncertain significance, Bardet-Biedl syndrome
- G62V (p.Gly62Val), rs755090554, gnomAD 11-66514429-TG-T, CADD 23.00
- G62C (p.Gly62Cys), gnomAD 11-66514430-G-T, REVEL 0.32, CADD 23.80
- G63R (p.Gly63Arg), TOPMed rs1856007407
- Q64E (p.Gln64Glu), rs369843749, ClinGen CA6123287, ClinVar RCV000268188, ClinVar RCV001243569, REVEL 0.10, CADD 16.50, Conflicting interpretations, Inborn genetic diseases; Bardet-Biedl syndrome; Bardet-Biedl syndrome 1
- Q64H (p.Gln64His), rs2495736173, ClinGen CA381455736, ClinVar RCV004426039, ClinVar RCV005051436, REVEL 0.28, CADD 19.20, Uncertain significance, Inborn genetic diseases; Bardet-Biedl syndrome 1
- Q65K (p.Gln65Lys), ExAC rs756964235, gnomAD rs756964235, REVEL 0.27, CADD 15.90
- Q65R (p.Gln65Arg), rs1856007588, ClinGen CA381455762, ClinVar RCV001054281, Ensembl rs1856007588, AlphaMissense 0.08, MetaLR 0.50, Uncertain significance, Bardet-Biedl syndrome
- P66S (p.Pro66Ser), Ensembl rs1565281462
- P66T (p.Pro66Thr), gnomAD 11-66514442-C-A, REVEL 0.59, CADD 22.60
- R67C (p.Arg67Cys), rs767385250, ClinGen CA6123289, cosmic curated COSV59147, ClinVar RCV001934991, REVEL 0.26, CADD 13.90, Uncertain significance, Bardet-Biedl syndrome 1; Bardet-Biedl syndrome
- R67H (p.Arg67His), rs145718265, ClinGen CA6123290, ClinVar RCV001107113, ClinVar RCV001242391, REVEL 0.23, CADD 19.90, Uncertain significance, Inborn genetic diseases; not specified; not provided
- R67L (p.Arg67Leu), ESP rs145718265, ExAC rs145718265, TOPMed rs145718265, gnomAD rs145718265, Uncertain significance
- R67G (p.Arg67Gly), rs1252698264, gnomAD 11-66514414-A-G, CADD 10.80
- R67* (p.Arg67Ter), rs748732460, gnomAD 11-66514480-C-T, CADD 0.33
Public BBS1 analysis runs
- BBS1 analysis run — BBS1 (912 variants) — completed 2026-08-21